Skip to main content

Market Overview

34 Healthcare Stocks Moving In Friday's Pre-Market Session

Share:

Gainers

  • Acorda Therapeutics, Inc. (NASDAQ: ACOR) shares moved upwards by 13.8% to $2.23 during Friday's pre-market session. According to the most recent rating by JP Morgan, on October 24, the current rating is at Underweight.
  • Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) stock increased by 11.1% to $0.23.
  • Chembio Diagnostics, Inc. (NASDAQ: CEMI) stock increased by 10.1% to $5.02.
  • BOQI International, Inc. (NASDAQ: BIMI) stock moved upwards by 8.8% to $3.73.
  • Aethlon Medical, Inc. (NASDAQ: AEMD) shares surged 3.2% to $1.29.
  • Onconova Therapeutics, Inc. (NASDAQ: ONTX) shares rose 3.1% to $0.43.
  • Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) shares surged 2.3% to $0.22. The most recent rating by Maxim Group, on October 23, is at Buy, with a price target of $1.00.
  • Endo International, Inc. (NASDAQ: ENDP) stock rose 2.2% to $4.60.
  • Guardion Health Sciences, Inc. (NASDAQ: GHSI) stock increased by 2.0% to $0.26.

 

Losers

  • Novan, Inc. (NASDAQ: NOVN) stock declined 74.0% to $0.81 during Friday's pre-market session.
  • Mereo BioPharma Group, Inc. (NASDAQ: MREO) shares fell 12.8% to $2.80.
  • Pulmatrix, Inc. (NASDAQ: PULM) stock fell 10.5% to $1.45.
  • Viveve Medical, Inc. (NASDAQ: VIVE) shares fell 9.1% to $1.00. According to the most recent rating by Ladenburg Thalmann, on December 03, the current rating is at Buy.
  • Jaguar Health, Inc. (NASDAQ: JAGX) shares declined 8.3% to $0.72. The most recent rating by H.C. Wainwright, on November 18, is at Buy, with a price target of $3.00.
  • Cassava Sciences, Inc. (NASDAQ: SAVA) shares fell 7.8% to $6.64.
  • Diffusion Pharmaceuticals, Inc. (NASDAQ: DFFN) stock fell 6.4% to $0.43. The most recent rating by H.C. Wainwright, on December 18, is at Buy, with a price target of $3.50.
  • Neovasc, Inc. (NASDAQ: NVCN) stock declined 5.9% to $3.65. The most recent rating by H.C. Wainwright, on October 24, is at Buy, with a price target of $9.00.
  • Agile Therapeutics, Inc. (NASDAQ: AGRX) stock fell 3.7% to $2.86.
  • Rite Aid, Inc. (NYSE: RAD) shares declined 3.5% to $14.00.
  • MorphoSys, Inc. (NASDAQ: MOR) stock plummeted 3.4% to $34.78. According to the most recent rating by Guggenheim, on November 20, the current rating is at Buy.
  • Genfit, Inc. (NASDAQ: GNFT) shares declined 2.9% to $20.07.
  • Genmab, Inc. (NASDAQ: GMAB) stock declined 2.7% to $21.69. The most recent rating by HC Wainwright & Co., on October 16, is at Buy, with a price target of $25.00.
  • SmileDirectClub, Inc. (NASDAQ: SDC) stock fell 2.4% to $8.12. The most recent rating by Goldman Sachs, on December 18, is at Neutral, with a price target of $10.00.
  • Mednax, Inc. (NYSE: MD) shares plummeted 2.4% to $26.84. The most recent rating by Citigroup, on January 03, is at Neutral, with a price target of $29.00.
  • Galapagos, Inc. (NASDAQ: GLPG) shares fell 2.2% to $207.50. According to the most recent rating by UBS, on December 20, the current rating is at Neutral.
  • Teva Pharmaceutical Indus, Inc. (NYSE: TEVA) stock fell 2.1% to $9.36. According to the most recent rating by JP Morgan, on November 12, the current rating is at Neutral.
  • Amarin Corp, Inc. (NASDAQ: AMRN) stock declined 2.0% to $21.10. The most recent rating by Oppenheimer, on December 16, is at Underperform, with a price target of $8.00.
  • Grifols, Inc. (NASDAQ: GRFS) stock declined 1.5% to $23.25. According to the most recent rating by Santander, on October 28, the current rating is at Buy.
  • Bristol-Myers Squibb, Inc. (NYSE: BMY) stock fell 1.5% to $62.38. The most recent rating by Argus Research, on December 13, is at Buy, with a price target of $80.00.
  • GlaxoSmithKline, Inc. (NYSE: GSK) stock decreased by 1.4% to $46.25. According to the most recent rating by UBS, on November 21, the current rating is at Buy.
  • Biocept, Inc. (NASDAQ: BIOC) shares declined 1.4% to $0.34.
  • Canopy Growth, Inc. (NYSE: CGC) shares fell 1.4% to $19.85. According to the most recent rating by Bank of America, on November 20, the current rating is at Buy.
  • AstraZeneca, Inc. (NYSE: AZN) stock declined 1.4% to $49.71. The most recent rating by Cowen & Co., on December 02, is at Outperform, with a price target of $55.00.
  • Qiagen, Inc. (NYSE: QGEN) shares plummeted 1.3% to $33.49. The most recent rating by Bank of America, on December 26, is at Underperform, with a price target of $28.00.
 

Related Articles (ACOR + AEMD)

View Comments and Join the Discussion!

Posted-In: Healthcare Stocks Pre-Market MoversNews Movers & Shakers Pre-Market Outlook Markets Movers Trading Ideas General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com